CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled
Drug / intervention
Respiratory rate measure based on PPGdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05856422
NCT05856422N/ACompleted

Respiratory Rate Validation Study - Gabi SmartCare Gabi Band

Gabi SmartCare·interventional·Posted May 12, 2023·Updated Nov 26, 2024

In Brief

A clinical study evaluating Respiratory rate measure based on PPG for Measure Accuracy of Respiratory Rate. Completed, enrolled 24 participants across 1 site.

Detailed Summary

The purpose of this study is to conduct a Respiratory Rate accuracy validation on pediatrics population comparing the Gabi SmartCare Gabi Band to the Reference, an FDA cleared End Tidal Carbon Dioxide monitor (GE Datex- Ohmeda) by manually scoring the collected waveform for data analysis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedMay 12, 2023
Enrollment StartDec 5, 2022
Primary CompletionDec 29, 2022
TodayJul 2, 2026
Enrollment to primary: 24 daysPosted 3.1 years ago

Interventions

Respiratory rate measure based on PPGdevice

Testing was conducted under normal office environment conditions. Each subject was connected to the reference EtCO2 monitor (GE Datex-Ohmeda) and the Device Under Test, the Gabi SmartCare Gabi Band. A waveform collected from an EtCO2 measurement was used to determine performance of respiratory rate metrics. Each subject was given a nasal cannula that allowed for measurement of the EtCO2 respiratory rate. The reference respiratory rate was measured simultaneously with the Device Under Test. Data was marked for stable quiet periods that were useable for analysis.